Tag: prescription drugs

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.

Senate HELP Minority report says 688 drug prices rose after Trump took office, with some cancer therapies now over $200,000 a year and a rare-disease drug jumping 1,555 percent; White House tariffs and the One Big Beautiful Bill Act could push costs higher still.

Analysts warn of price risks even as generics, U.S. facilities, and European caps could blunt the impact.

ProPublica identified more than 150 products that were exempted from import bans since 2013.

Order pushes for four-year delay in Medicare price talks for most prescription drugs, echoing pharma lobby demands and risking higher costs for patients.

As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics could sell for a fraction of the cost.

Economic parity in health emergence: Sanders' rallying cry for global equity in WHO pandemic accord.

Sanders demanded a probe of the National Institutes of Health (NIH) patent proposal in a letter to Christi Grimm, inspector general of the U.S. Department of Health and Human Services.

"This is the biggest defeat Big Pharma has ever suffered—and it won't be the last. We are going to keep fighting until every single person in America can get the medications they need."

The best way to get alternatives to the current patent system was to have examples of successful drugs developed without relying on patent monopolies.